相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coagulation factor VIII: Relationship to cardiovascular disease risk and whole genome sequence and epigenome-wide analysis in African Americans
Laura M. Raffield et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Genotyping Array Design and Data Quality Control in the Million Veteran Program
Haley Hunter-Zinck et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2020)
Sex Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease
Anurag Mehta et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
A critical role for plasminogen in inflammation
Sarah K. Baker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Interferon gamma-induced protein 10 (IP-10) and cardiovascular disease in African Americans
Colton Leavitt et al.
PLOS ONE (2020)
Comparison of Proteomic Assessment Methods in Multiple Cohort Studies
Laura M. Raffield et al.
PROTEOMICS (2020)
Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction Results From the PROMIS-HFpEF Study
Sandra Sanders-van Wijk et al.
CIRCULATION (2020)
Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis
Jens Emil Vang Petersen et al.
BMJ OPEN (2020)
The GTEx Consortium atlas of genetic regulatory effects across human tissues
Francois Aguet et al.
SCIENCE (2020)
A simple and accurate method to determine genomewide significance for association tests in sequencing studies
Dan-Yu Lin
GENETIC EPIDEMIOLOGY (2019)
Whole genome sequence association with E-selectin levels reveals loss-of-function variant in African Americans
Linda M. Polfus et al.
HUMAN MOLECULAR GENETICS (2019)
Circulating proteins as predictors of incident heart failure in the elderly
Markus Stenemo et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
FUN-LDA: A Latent Dirichlet Allocation Model for Predicting Tissue-Specific Functional Effects of Noncoding Variation: Methods and Applications
Daniel Backenroth et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
Niaz Mahmood et al.
FRONTIERS IN ONCOLOGY (2018)
Co-regulatory networks of human serum proteins link genetics to disease
Valur Emilsson et al.
SCIENCE (2018)
Identification of Common and Rare Genetic Variation Associated With Plasma Protein Levels Using Whole-Exome Sequencing and Mass Spectrometry
Terry Solomon et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
Plasmin: A Modulator of Immune Function
Dominik Draxler et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Plasmin(ogen) at the Nexus of Fibrinolysis, Inflammation, and Complement
Jonathan Foley
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure
Lorenz Koller et al.
JACC-HEART FAILURE (2017)
D-Dimer in African Americans Whole Genome Sequence Analysis and Relationship to Cardiovascular Disease Risk in the Jackson Heart Study
Laura M. Raffield et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease
William J. Astle et al.
CELL (2016)
suPAR: A New Biomarker for Cardiovascular Disease?
Gethin W. Hodges et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
Soluble urokinase plasminogen activator receptor-A valuable biomarker in systemic lupus erythematosus?
Helena Enocsson et al.
CLINICA CHIMICA ACTA (2015)
suPAR: The unspecific marker for disease presence, severity and prognosis
Jesper Eugen-Olsen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Soluble urokinase plasminogen activator receptor as a prognostic marker of all-cause and cardiovascular mortality in a black population
Shani Botha et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease
Bjorn Meijers et al.
KIDNEY INTERNATIONAL (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation
Yan Borne et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels
Michael A. Portelli et al.
FASEB JOURNAL (2014)
Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments
Pouya Kheradpour et al.
NUCLEIC ACIDS RESEARCH (2014)
Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events
Danny J. Eapen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score
Stig Lyngbaek et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Urokinase Plasminogen Activator Receptor: A Functional Integrator of Extracellular Proteolysis, Cell Adhesion, and Signal Transduction
Gian Maria Sarra Ferraris et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmo Diet and Cancer Study
M. Persson et al.
ATHEROSCLEROSIS (2012)
Population-specific coding variant underlies genome-wide association with adiponectin level
Damien C. Croteau-Chonka et al.
HUMAN MOLECULAR GENETICS (2012)
Soluble Urokinase Plasminogen Activator Receptor is Associated With Inflammation in the Vulnerable Human Atherosclerotic Plaque
Andreas Edsfeldt et al.
STROKE (2012)
A Genetic Variation Located in the Promoter Region of the UPAR (CD87) Gene Is Associated With the Vascular Complications of Systemic Sclerosis
Mirko Manetti et al.
ARTHRITIS AND RHEUMATISM (2011)
Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events
T. Sehestedt et al.
ATHEROSCLEROSIS (2011)
Pericardial Adipose Tissue, Atherosclerosis, and Cardiovascular Disease Risk Factors The Jackson Heart Study
Jiankang Liu et al.
DIABETES CARE (2010)
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
J. Eugen-Olsen et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Regulation of cell signalling by uPAR
Harvey W. Smith et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Larry Gold et al.
PLOS ONE (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
suPAR: The molecular crystal ball
Maria Thuno et al.
DISEASE MARKERS (2009)
Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study)
Ervin R. Fox et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Development of a large-scale de-identified DNA biobank to enable personalized medicine
D. M. Roden et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Calcified coronary artery plaque measurement with cardiac CT in population-based studies: Standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study
JJ Carr et al.
RADIOLOGY (2005)
Laboratory, reading center, and coordinating center data management methods in the Jackson heart study
MA Carpenter et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2004)
Transcriptional regulation of the urokinase receptor (u-PAR) - A central molecule of invasion and metastasis
T Fuchs et al.
BIOLOGICAL CHEMISTRY (2003)
分享论文
